Group F Streptococcus: Pathogenesis and Antibiotic Resistance

Group F streptococcus belongs to the Streptococcus anginosus group, a trio of species with an unusual talent for burrowing into deep tissues and forming abscesses. While less familiar than its cousins in groups A and B, group F strep causes serious pyogenic infections ranging from lung abscesses and empyema to bacteremia and meningitis. Most isolates remain susceptible to penicillin, but emerging research on mobile genetic elements suggests these bacteria may be quietly accumulating resistance genes and passing them to other streptococci.

A Naming Problem That Matters Clinically

The terminology around group F streptococcus confuses even seasoned clinicians. The Lancefield grouping system, developed in the 1930s, classifies streptococci by the carbohydrate antigens on their cell walls. Group F strep carries the F antigen, but the organisms that carry it do not belong to a single species. Instead, they sit within the Streptococcus anginosus group, sometimes still called the Streptococcus milleri group in older literature. This group contains three recognized species: S. anginosus, S. constellatus, and S. intermedius. Any of them can carry the Lancefield F antigen, though S. anginosus does so most frequently.

Phylogenetic analysis using multiple housekeeping genes has identified at least seven distinct clusters within the anginosus group, and single-gene sequencing often fails to distinguish between species because of extensive allele sharing.¹ That genetic promiscuity is not just a taxonomic headache. It means the organisms readily swap genetic material, including sequences that influence virulence and drug resistance. It also means that a lab report reading “group F beta-hemolytic streptococcus” could represent any of several subspecies with somewhat different clinical profiles.

How Group F Strep Gets a Foothold

Group F streptococci are normal inhabitants of the human mouth, upper respiratory tract, gastrointestinal tract, and urogenital mucosa. Most of the time they coexist peacefully with their host. Trouble starts when they breach a mucosal barrier, whether through aspiration, abdominal perforation, dental procedures, or some other disruption. Once they reach a normally sterile site, several surface features help them stick and survive.

One key adhesin is a fibronectin-binding protein. Fibronectin is a glycoprotein found on cell surfaces and in connective tissue matrices, and streptococci that latch onto it gain a physical anchor in host tissue. Research on S. anginosus demonstrated that the organisms bind fibronectin at the cell surface through a roughly 14-kilodalton protein, with each bacterial cell carrying around 770 binding sites. That binding increased adhesion to hydroxyapatite, a mineral component of bone and teeth, which helps explain why these bacteria can colonize heart valves and joint spaces.²

A second adhesin targets laminin, a protein found in basement membranes throughout the body. An endocarditis isolate of S. anginosus was shown to adhere to exposed basement membrane of human and porcine heart valve tissue in a laminin-dependent way. The responsible molecule is an 80-kilodalton protein whose amino acid sequence resembles substrate-binding proteins of ABC transporters found in other gram-positive cocci.³ Together, fibronectin and laminin binding give group F strep the means to colonize damaged tissue and exposed basement membrane, two conditions that arise readily after surgery, trauma, or other infections.

The Abscess Specialists

The defining clinical feature of the Streptococcus anginosus group, and of group F strep in particular, is their tendency to form abscesses. While many bacteria can trigger abscess formation under the right circumstances, the anginosus group does it with striking consistency. Brain abscesses, liver abscesses, lung abscesses, intra-abdominal collections, and soft-tissue abscesses all appear in the literature, sometimes in patients with no obvious immune deficiency.

Part of this abscess-forming talent comes from cooperation with other bacteria. Experimental work showed that when members of the S. milleri group were co-inoculated with Fusobacterium nucleatum, a common oral anaerobe, the resulting abscesses were larger and contained higher bacterial counts than when either organism was injected alone. The strongest synergistic effect occurred with S. constellatus, but S. anginosus and S. intermedius also showed enhanced abscess formation in mixed infections.⁴ This synergy matters in real-world infections because group F strep rarely acts alone. It typically inhabits polymicrobial environments, and the anaerobes it shares space with in the mouth and gut amplify its destructive potential.

The clinical consequences can escalate quickly. A case report documented a patient who developed empyema, a collection of pus in the pleural space, from group F beta-hemolytic S. anginosus. The infection progressed rapidly enough to require CT-guided chest tube drainage alongside intravenous antibiotics. The patient received ceftaroline initially and was later transitioned to ertapenem, spending 11 days in the hospital before discharge.⁵ That speed of progression is characteristic: group F strep infections tend to be aggressive, and delay in drainage or surgical intervention can lead to complications.

Beyond Abscesses

While deep-seated abscesses are the hallmark, group F streptococcus causes a broader range of infections than many clinicians expect. Bacteremia without an obvious abscess source has been documented, and when it occurs in adults, clinicians should search carefully for a hidden collection. Septic arthritis is another recognized presentation. In one reported case, antimicrobial therapy alone led to complete resolution of group F streptococcal arthritis, though the authors noted how unusual the organism was as a joint pathogen.⁶

Pediatric infections deserve separate mention because they are rare but can be severe. A review from a single institution identified three cases of group F beta-hemolytic streptococcal bacteremia in previously healthy children over a ten-year period. Two of those children developed meningitis, and one had perforated appendicitis with peritonitis.⁷ The takeaway is that while group F strep infections in children are uncommon, they should not be dismissed as contaminants when isolated from blood cultures in a child who is clinically unwell.

Antibiotic Susceptibility and Treatment

The good news is that group F streptococcus and its anginosus group relatives remain broadly susceptible to beta-lactam antibiotics, the class that includes penicillin and its derivatives. A tertiary care hospital study analyzing S. anginosus group infections found overall penicillin susceptibility at about 91%, making beta-lactams the recommended first-line treatment.⁸ That figure, though reassuring, means roughly one in ten isolates showed reduced susceptibility, a proportion worth keeping in mind when choosing empiric therapy for a seriously ill patient.

For deep-seated infections like abscesses and empyema, antibiotics alone are usually insufficient. The case literature consistently emphasizes the need for source control, meaning drainage of pus collections through percutaneous catheters or surgery. The combination of appropriate antibiotics and timely drainage is the cornerstone of management.⁵ For intra-abdominal abscesses and solid organ collections, guidelines suggest adding anaerobic and gram-negative coverage to the beta-lactam backbone, since these infections are almost always polymicrobial.⁸

What about patients allergic to penicillin? Macrolides like erythromycin and clindamycin have been traditional alternatives for streptococcal infections broadly, but resistance to these agents has been climbing across streptococcal species for years. When treating a serious group F strep infection in a penicillin-allergic patient, susceptibility testing is essential rather than assumed.

A Growing Reservoir of Resistance Genes

The most concerning finding in recent research is not that group F strep is widely resistant right now, but that it may be accumulating the genetic machinery to become so. A 2025 study examining the “mobilome” of S. anginosus, meaning the collection of mobile genetic elements that can shuttle between bacteria, found a striking diversity of resistance-carrying structures. Researchers identified 47 well-characterized mobile genetic elements, including 23 integrative and conjugative elements, 16 prophages or integrative mobilizable elements, and 8 composite structures formed by successive accretion events.⁹

What makes this particularly worrying is that these mobile elements are not unique to S. anginosus. They resemble elements found widely across other streptococcal species, suggesting that S. anginosus may function as a repository, collecting resistance genes from its neighbors and potentially redistributing them. The composite structures, formed when multiple mobile elements pile up at the same chromosomal location, can carry clusters of resistance genes in a single transferable package.⁹

This fits into a broader pattern observed across beta-hemolytic streptococci. Work on group G streptococcus identified a novel integrative conjugative element that could transfer not just to other group G isolates, but also to group A and group B streptococci.¹⁰ The streptococcal world, in other words, is a community where genetic information flows freely between species and Lancefield groups. Group F strep sits in the middle of this exchange network, sharing niches with groups A, B, C, and G in the throat and gut, and its genetic flexibility may make it an especially effective intermediary for resistance gene dissemination.

Why Laboratory Identification Can Be Tricky

Identifying group F streptococcus in the lab is not always straightforward, and misidentification can lead to inappropriate treatment decisions. The Lancefield serotyping system, which uses antisera to detect cell-wall carbohydrate antigens, can produce cross-reactions. Research demonstrated that streptococcal group C antiserum cross-reacts with pneumococcal F antigen, which means a lab relying solely on serological grouping could misclassify an organism.¹¹

Molecular methods offer more reliable identification. A PCR approach targeting the penicillin-binding protein 2B gene amplifies a specific fragment from all members of the anginosus group but not from other streptococci, providing a clean group-level identification. Further differentiation to the species or subspecies level is then possible with a multiplex PCR targeting the 16S ribosomal RNA gene and species-specific virulence genes like hyaluronate lyase and intermedilysin.¹² In practice, many clinical microbiology labs still report these isolates as “Streptococcus anginosus group” or “viridans group streptococcus” without full speciation, which can lead clinicians to underestimate the pathogenic potential of what they are dealing with.

Genomic Variability Within the Group

Whole-genome sequencing has revealed that S. anginosus is the most genetically variable species in the anginosus group, with both the smallest and largest genomes recorded, along with multiple genomic rearrangements, insertions, and deletions. By contrast, S. constellatus and S. intermedius show extensive continuous synteny with only modest differences in genome size between strains.¹³

That variability has practical implications. A highly plastic genome means S. anginosus can acquire and rearrange genetic material more readily than its more conserved relatives. It is consistent with the observation that S. anginosus harbors a disproportionate load of mobile genetic elements carrying resistance genes. From an evolutionary standpoint, the species appears to be under strong selective pressure to maintain genomic flexibility, perhaps because it occupies such diverse niches across the human body, from the oral cavity to the gastrointestinal and urogenital tracts. Each niche exposes the organism to different antimicrobial pressures and different microbial neighbors with different genetic cargo to share.

The Zoonotic Connection

Group F streptococcus is primarily a human commensal and pathogen, but closely related beta-hemolytic streptococci circulate in animal populations too, raising questions about cross-species transmission. A genetic study of Streptococcus dysgalactiae isolates from sheep found that some ovine strains shared identical sequence types and emm gene sequences with human invasive and non-invasive isolates. Phylogenetic analysis grouped certain sheep isolates together with human strains associated with zoonotic infections.¹⁴

While S. dysgalactiae is typically classified as group C or G rather than group F, the relevance lies in the broader streptococcal ecology. The same mobile genetic elements that shuttle resistance genes between human streptococcal species could also move between animal and human strains when opportunities for contact exist. Farmers, veterinarians, and slaughterhouse workers represent the populations most likely to encounter animal streptococci, and any resistance genes those animal strains carry could, at least in theory, make their way into the human streptococcal gene pool. This “One Health” dimension of streptococcal resistance is still in its early stages of investigation, but the genetic overlap between human and animal isolates suggests the risk is not hypothetical.

When to Suspect Group F Strep

Because group F streptococcus does not get the same clinical attention as groups A and B, infections are sometimes recognized late. Certain clinical scenarios should raise suspicion. A patient presenting with a rapidly developing pleural effusion or empyema, especially after aspiration or a dental procedure, is a classic scenario. Deep abscesses in the liver, brain, or peritoneal cavity, particularly when they arise in someone without the usual risk factors like immunosuppression or recent abdominal surgery, are another red flag. The organism’s ability to cause purulent disease in otherwise healthy people is part of what makes it dangerous: clinicians may not think to look for a streptococcal species that most medical training barely mentions.

Blood cultures that grow “viridans group streptococcus” or “Streptococcus anginosus group” in a patient who looks sicker than that label implies should prompt further workup. The reflexive response to viridans streptococci in blood cultures is often to consider contamination or low-grade endocarditis, but the anginosus group members are fundamentally different from the other viridans streptococci. They cause suppurative, tissue-destructive disease, and a positive blood culture often signals a hidden abscess that needs to be found and drained.

For pediatric patients, the threshold for concern should be even lower. The rarity of group F strep bacteremia in children means each case could represent a serious underlying process, as illustrated by the meningitis and perforated appendicitis cases described earlier.⁷ A blood culture positive for group F strep in a child should never be assumed to be a contaminant.